Actin's polymerization properties are markedly altered by oxidation of its conserved Met 44 residue. Mediating this effect is a specific oxidation-reduction (redox) enzyme, Mical, that works with Semaphorin repulsive guidance cues and selectively oxidizes Met 44. We now find that this actin-regulatory process is reversible. Employing a genetic approach, we identified a specific methionine sulfoxide reductase (MsrB) enzyme SelR that opposes Mical redox activity and Semaphorin-Plexin repulsion to direct multiple actin-dependent cellular behaviours in vivo. SelR specifically catalyses the reduction of the R isomer of methionine sulfoxide (methionine-R -sulfoxide) to methionine, and we found that SelR directly reduced Mical-oxidized actin, restoring its normal polymerization properties. These results indicate that Mical oxidizes actin stereospecifically to generate actin Met-44-R -sulfoxide (actin Met(R)O−44 ), and also implicate the interconversion of specific Met/Met(R )O residues as a precise means to modulate protein function. Our results therefore uncover a specific reversible redox actin regulatory system that controls cell and developmental biology.
Identifying the factors that shape the actin cytoskeleton, the basic building blocks of cellular form and function, is a critical biomedical goal 1, 2 . Interestingly, actin is susceptible to post-translational modification of its amino acid residues but the physiological importance of these covalent modifications is still poorly understood 3 . Recently, we found that actin's polymerization properties are altered by specific oxidation of its conserved Met 44 residue on the pointed-end of actin subunits 4 . These observations raise issues of the susceptibility of this residue to pathological modification 3 , but we have also identified a specific redox enzyme, Mical, that selectively oxidizes Met 44 to disassemble actin filaments (F-actin) and impair actin polymerization 4, 5 . Our results reveal that Mical uses F-actin as a direct substrate, employing an oxidation-dependent post-translational mechanism to regulate filament dynamics 4 .
MICAL family proteins, which include one Drosophila Mical and three mammalian MICALs, regulate numerous cellular events in different tissues, including morphology, motility, navigation, exocytosis and survival (reviewed in refs [6] [7] [8] [9] . At least some of these effects occur through the ability of MICALs to regulate actin cytoskeletal organization 4, 5, [10] [11] [12] . Interestingly, MICALs also directly link one of the largest families of extracellular guidance cues, the Semaphorins and their Plexin cell surface receptors, to changes in the actin cytoskeleton 5, 13 . Semaphorins are the largest family of repulsive guidance cues 14, 15 and have been characterized for their ability to disassemble F-actin and 'collapse' the actin cytoskeleton of multiple different cell types 6, 16 . MICALs directly bind to the Semaphorin receptor Plexin through their carboxy termini 13, 17 and employ their actin-binding/regulatory redox domain to mediate the destabilizing effects of Semaphorins-Plexins on the actin cytoskeleton 5 . These effects include a loss of F-actin, the decreased ability to polymerize new F-actin, a decrease in the number of F-actin bundles, and the regulation of F-actin-rich filopodia/branches 6 .
We now find a specific methionine sulfoxide reductase enzyme SelR/MsrB that selectively reverses this Mical-mediated oxidation of actin. SelR counteracts Mical in vivo to direct multiple actin-dependent cellular processes including axon guidance, synaptogenesis, muscle organization and mechanosensory development. SelR also neutralizes Semaphorin-Plexin repulsion. Thus, Mical and SelR comprise a reversible redox cellular signalling system that orchestrates proper cytoskeletal-mediated physiology.
RESULTS

SelR counteracts Mical-mediated F-actin alterations in vivo
Mical directs the organization of actin in a number of different cell types 4, 5, [10] [11] [12] including within developing bristle processes, which are akin to mammalian mechanotransducing inner ear hair cells that detect sound 18, 19 . Bristles have also long served as a simple, single-cell model for characterizing actin-dependent events in vivo 5, 20, 21 levels of Mical specifically in bristle cells using the GAL4-UAS (ref. 22) system (bristle-specific GAL4/UAS:Mical) results in F-actin disassembly and bristle branching (compare Fig. 1a with Fig. 1b ) that is dependent on Mical's redox activity and the Met 44 residue of actin 4, 5 . Thus, to better characterize Mical-mediated F-actin alterations, we have initiated a large-scale genetic screen to look for enhancers and suppressors of Mical-mediated bristle branching. One of the mutations that we identified in our genetic screen, the transposable element mutation EY22443, strongly suppressed Mical-induced actin-dependent bristle branching ( Fig. 1b-d ). Molecular analysis revealed that the EY22443 transposable element mutation was situated within the Drosophila SelR gene ( Fig. 1e ). SelR codes for a methionine sulfoxide reductase (MsrB) family enzyme, that has been characterized for its ability to reduce oxidized methionine residues 23 . In light of our observations that Mical oxidizes methionine residues on actin 4 , we wondered whether SelR might play a role in modulating Mical's effects on actin. The EY22443 transposable element mutation situated in SelR contains a UAS promoter ( Fig. 1e ), thereby suggesting that this mutation might be abnormally inducing SelR expression to suppress GAL4/UAS:Mical-dependent bristle branching. To test this hypothesis, we generated transgenic flies expressing SelR directly under the UAS promoter. Consistent with our results with EY22443 ( Fig. 1c,d ) and another UAS-containing mutation within SelR, EP3340 (Fig. 1d ), multiple transgenic lines revealed that raising the levels of SelR specifically in bristles strongly suppressed Mical-induced bristle branching and even generated normal appearing bristles ( Fig. 1f ). Moreover, elevating the levels of SelR in a wild-type background generated abnormally bent bristles that resembled Mical −/− mutant bristles ( Supplementary Fig. 1 and ref. 5); and these effects of SelR were genetically enhanced by decreasing the levels of Mical ( Supplementary  Fig. 1 ). Further analysis revealed that SelR localized with Mical at the tips of bristles and suppressed Mical-mediated F-actin disassembly and reorganization ( Fig. 1f ). Therefore, SelR counteracts the effects of Mical on actin reorganization in vivo.
SelR restores the polymerization of Mical-treated actin
To better understand the role of SelR in counteracting Mical-mediated actin reorganization, we purified recombinant Drosophila SelR protein ( Supplementary Fig. 2 ). Using in vitro actin biochemical and imaging assays, we previously observed that purified Mical protein in the presence of its coenzyme NADPH disrupts actin polymerization and induces F-actin disassembly 4,5 ( Fig. 2a ). Strikingly, we found that purified SelR protein rescued the ability of Mical-treated actin to polymerize ( Fig. 2a ). This Mical/SelR-treated actin re-polymerized to an extent that was indistinguishable from normal untreated actin ( Fig. 2b) . Moreover, whereas Mical-treated actin failed to polymerize even after removal of Mical and NADPH ( Fig. 2c and ref. 4) , SelR induced the polymerization of this purified Mical-treated actin in a dosage-dependent manner (Fig. 2c ). Thus, SelR restores the polymerization properties of Mical-treated actin.
SelR converts methionine sulfoxide (MetO) to methionine 23, 24 , requiring a redox-active cysteine (Cys124) residue 25 (Fig. 2d ,e) and also using reducing agents to cycle back to its reduced form 24, 25 (Fig. 2d and Supplementary Fig. 3 ). In some cases methionine oxidation is also reversed by general reducing agents 26 , so we wondered whether Mical-treated actin was specifically reversed by SelR. In contrast to SelR, neither chemical reducing agents such as dithiothreitol (DTT; Fig. 2a (buffer contains only DTT); Supplementary Fig. 3 ) nor other reducing enzymes including thioredoxins/thioredoxin reductases altered Micalmediated effects on actin in vitro ( Supplementary Fig. 3 ) or in vivo (Fig. 1d ). Furthermore, SelR did not restore the normal polymerization properties of other oxidized forms of actin (for example, H 2 O 2 -treated actin; Supplementary Fig. 3 ), indicating that SelR selectively affects Mical-modified actin. Mutating the critical catalytic cysteine of SelR (Cys124) to generate an enzymatically dead SelR (SelR C124S ; Fig. 2e and ref. 25) abolished the effects of SelR on Mical-treated actin in vitro (Fig. 2b ,f) and in vivo ( Fig. 2g ). Moreover, consistent with such a role for the reductase activity of SelR in counteracting Mical's oxidative effects on actin, elevating the levels of wild-type SelR not only phenocopied the in vivo effects of disrupting Mical's monooxygenase (redox) domain ( Supplementary Figs 1 and 4 ), but it also rescued the severe bristle/F-actin alterations that result from hyperactive Mical redox signalling 5 ( Supplementary Fig. 4 ; Mical redoxCH ). Thus, SelR specifically employs its catalytic activity to restore Mical-treated actin polymerization and counteract the in vivo effects of Mical.
SelR reverses Mical-mediated actin Met 44 oxidation
In many organisms, including Drosophila and mammals, two main types of methionine sulfoxide reductase have been identified: SelR (MsrB family proteins) and Drosophila Eip71CD (MsrA; Fig. 3a and ref. 27 ). Interestingly, SelR and MsrA/Eip71CD are both methionine sulfoxide reductases, but they do not exhibit similarity in their sequence, domain organization or substrate specificity 27 (Fig. 3a,b ). In particular, methionine has a unique oxidation pattern in that two stereoisomers can be produced by oxidation 27 . SelR/MsrB family proteins catalyse the reduction of the R isomer of methionine sulfoxide (methionine-Rsulfoxide; Fig. 3b , top) to methionine, whereas MsrA/Eip71CD catalyses the reduction of the S-isomer of methionine sulfoxide (methionine-S-sulfoxide; Fig. 3b , bottom) to methionine 23, 25, 27 . Therefore, to further test the specificity of SelR in restoring the polymerization properties of Mical-treated actin, we purified recombinant MsrA/Eip71CD protein 25 ( Supplementary Fig. 2 ). Unlike SelR, MsrA/Eip71CD did not restore the polymerization properties of Mical-treated actin in vitro ( Fig. 3c ), nor did it counteract Mical-mediated actin reorganization/bristle branching in vivo (Fig. 1d ). These results further reveal that Mical-treated actin polymerization is specifically restored by SelR. Moreover, in light of the isomer-specific nature of the methionine sulfoxide enzymes SelR and MsrA/Eip71CD, these results also indicate that Mical oxidizes actin in a stereospecific manner.
Mical oxidizes actin on its Met 44 and Met 47 residues, although it is the oxidation of the Met 44 residue through which Mical induces F-actin disassembly 4 . Thus, we wondered whether SelR directly reverses Mical-mediated oxidation of actin. Previously, we determined the conditions to purify Mical-treated actin, which is polymerization impaired and exhibits a mass increase of two oxygens (32 daltons) 4 . SelR, but not the enzymatically dead SelR C124S protein, restored the polymerization properties of purified Mical-treated actin ( Supplementary Fig. 3 ), an effect that was maintained even after removal of SelR ( Fig. 3d ). Subjecting both purified Mical/SelR-treated and Mical/SelR C124S -treated actin to mass spectrometry revealed that SelR, but not the enzymatically dead SelR C124S protein, eliminated the Mical-catalysed two-oxygen (32 dalton) mass increase on actin ( Fig. 3e ).
Mical's ability to effect actin in vitro and in vivo is dependent on the presence of the Met 44 residue of actin 4 . To further examine a physiological role for SelR in reducing Mical-mediated oxidation of Met 44, we turned to in vivo assays. We first noted that overexpression of either a non-Mical oxidizable M44L version of actin 4 or wild-type Supplementary Figs 1 and 4 ). Furthermore, we found that actin M44L worked in combination with SelR to generate Mical loss-of-function-like bristle defects ( Supplementary Fig. 4 ). Moreover, actin M44L prevented the enhanced Mical-mediated bristle branching/actin reorganization that occurred with expression of the reductase dead SelR C124S (Fig. 2g ). Thus, SelR reverses Mical-mediated oxidation of actin, including using its catalytic activity to directly reduce Mical-induced MetO 44 actin to Met 44 actin (Fig. 3f )-and these observations with purified proteins are supported by our in vivo genetic assays.
The Mical/SelR system regulates actin organization in multiple cell types
In addition to bristle cells, Mical regulates the organization of actin in multiple other cell types including mammalian cells in vitro and muscles in vivo [4] [5] [6] 10, 11 . Thus, we wondered whether SelR could also counteract the effects of Mical on actin in these other cellular systems. Our initial examination revealed that as in bristle cells, SelR rescued Mical-dependent changes in morphology and actin organization in cultured cells (Fig. 4a ). Further examination revealed that overexpression of SelR in muscles in vivo phenocopied the muscle actin defects found in Mical −/− mutants 10 (Fig. 4b ). Moreover, SelR could even rescue the lethality and changes in actin organization associated with overexpression of Mical in muscles ( Fig. 4c )-as well as the lethality that results when Mical is broadly expressed using an actin promoter ( Fig. 4c ). Drosophila SelR, like Mical, is broadly expressed 5,10,13,25,28-31 ( Supplementary Fig. 5 ) and thus to better examine these Mical-SelR interactions and their physiological effects on actin, we characterized SelR −/− mutants ( Supplementary Fig. 6 ). Strikingly, loss of SelR Mical −/− mutant muscles 10 . The percentage of muscles exhibiting abnormal accumulations of actin is shown (n = 24 muscles assessed in 9 animals per genotype). Replicated in at least two independent experiments (separate crosses) per genotype. Mical −/− = Mical G56 /Mical I666 . (c) SelR-mediated rescue of Mical -induced lethality and muscle actin defects. Mical overexpression (Mical+++) using either an actin promoter (Actin5C-GAL4) or a muscle-specific promoter (24B-GAL4) is lethal (graph). SelR (SelR+++) co-expression completely rescues this Mical-induced lethality (n = 100 animals examined per cross) and also rescues the changes in actin organization that result from Mical overexpression in muscles (n = 24 muscles assessed in 9 animals per genotype). Both experiments were replicated in at least two independent experiments (separate crosses) per genotype. generated bristle and muscle defects that resembled overexpression of Mical ( Fig. 5a,e ). Moreover, loss of SelR specifically enhanced Micalmediated effects on actin organization/bristle morphology (Fig. 5b,c and Supplementary Fig. 4 ) and phenocopied overexpression of the SelR C124S reductase mutant protein ( Fig. 5d ). Thus, SelR, like Mical, plays both important and selective roles in regulating actin organization in vivo in different cell types. Likewise, an equilibrium between Mical and SelR activities underlies normal actin-directed cell biology. 
SelR neutralizes Semaphorin-Plexin-Mical repulsive signalling
Besides its redox region that Mical uses to oxidize actin, Mical has several other domains and protein interaction motifs including a region that interacts with the cytoplasmic portion of Plexin ( Fig. 6a and  refs 13,17 ). Plexins are receptors for Semaphorin guidance cues and play critical roles in regulating multiple actin-dependent events in vivo 6, 32, 33 . Semaphorins-Plexins signal through Mical to induce changes in bristle morphology and F-actin disassembly 5 , so we wondered whether SelR also counteracted the effects of Semaphorin-Plexin-Mical signalling.
Employing loss-and gain-of-function genetics in the bristle system, we found that similar to our results with Mical, SelR counteracted Semaphorin-Plexin effects on actin-dependent bristle morphology ( Supplementary Fig. 1 ). Next, we turned to in vivo axon guidance assays, where Semaphorins-Plexins have been characterized as repulsive axon guidance molecules 15 and were first linked to MICAL family proteins 13 . Interestingly, one of the SelR mutants that we found in our screen (EP3340, Fig. 1d,e ) recently emerged from a genetic screen as an uncharacterized regulator of axon guidance 34 . See Supplementary Fig. 6d Employing our SelR transgenic lines, we found that overexpression of SelR generated axon guidance and synaptogenic defects that phenocopy Mical −/− mutants 5,10,13 ( Fig. 6b and Supplementary Fig. 6 ). Furthermore, SelR −/− mutants generated axon guidance defects that phenocopy increased Semaphorin-Plexin-Mical-mediated repulsive axon guidance 5,35-37 ( Fig. 6c and Supplementary Fig. 6 ). Moreover, increasing the levels of SelR rescued these Semaphorin-Plexin-Micaltriggered repulsive axon guidance defects ( Fig. 6d and Supplementary  Fig. 6 ). Thus, SelR also plays critical roles in axon guidance and synaptogenesis and counteracts the effects of Semaphorin-Plexin-Mical repulsive signalling in vivo.
DISCUSSION
Our results reveal that Mical-mediated actin alterations-a selective means to post-translationally regulate F-actin dynamics and cellular behaviours-are reversible. This Mical-catalysed reaction is directly reversed by a specific methionine sulfoxide reductase enzyme, SelR/MsrB, which we also find selectively controls actin-dependent cellular events in vivo and regulates specific neuronal, muscular and mechanosensory developmental processes. We also find that SelR counteracts Semaphorins, which are one of the largest families of extracellular guidance cues and play a critical role in the formation and function of multiple tissues 6, 32 . Thus, our results demonstrate an important role for these methionine sulfoxide reductases-enzymes thought to function primarily in the repair of oxidatively 'damaged' methionine residues 24,38in modulating normal signalling events. Moreover, our genetic data, which reveal that SelR and Mical loss-and gain-of-function phenotypes are opposite in appearance, indicate that SelR has a specific, primary, and regulated role in counteracting Mical during development. The Mical substrate Met 44 residue of actin is conserved in all actin family members from yeast to humans 4 and a dominant (hetereozygous) mutation in the Met 44 residue (M44T) of skeletal muscle actin underlies a human musculoskeletal disease associated with actin accumulation and aggregation (nemaline myopathy 39 ). This Met 44 mutant version of human skeletal muscle actin would be predicted to prevent Mical from having effects on skeletal muscle actin-and generally phenocopies both Mical −/− mutants and SelR muscle overexpression. However, the Met 44 residue is well conserved and is at a subunit interface in filaments 4, 40, 41 and thus mutating it may influence F-actin organization for reasons other than that it is non-oxidizable. It should be noted, however, that our previous results indicate that Met 44 mutant actin (M44L) seems to polymerize normally in vitro and in vivo, but is resistant to Mical-mediated F-actin disassembly 4 .
It is also interesting to note the differences in the cellular localization we see between SelR and different forms of Mical. For example, in bristles, SelR shows overlapping localization with Mical, but is more broadly distributed than full-length Mical, which strongly localizes to bristle tips 5 (Fig. 1f) . The broader cellular localization of SelR is similar to that seen when the hyperactive Mical redoxCH is expressed in bristles and other cells 5 (Fig. 4a) . One of the differences between full-length Mical and the hyperactive Mical redoxCH is the presence of the Plexin-interacting region 13 (Fig. 6a) . Our results indicate that full-length Mical is susceptible to regulation by Plexin, whereas the Mical redoxCH protein (which does not have the Plexin-interacting region) is not regulated by Plexin 5 (see also refs 11,17) . Interestingly, the MICALs express multiple different transcripts, including versions that may be similar to Mical redoxCH (ref. 6 ). Thus, there may be roles for both endogenous Semaphorin-Plexin-regulated and, perhaps, non Semaphorin-Plexin-regulated forms of Mical (which seem to be more generally localized in cells). In any case, it should be noted that we find that SelR rescues both the lethality and F-actin defects associated with overexpression of either full-length Mical or Mical redoxCH . Likewise, we find that SelR counteracts Semaphorin-Plexin effects in vivo.
Our results herein, coupled with our previous observations 4 , also indicate that unlike diffusible oxidants that induce random protein modifications 24, 38, 42 , Mical-mediated oxidation is substrate-, residueand stereo-specific. Our results indicate that Mical oxidizes the Met 44 residue of actin stereospecifically to generate actin methionine-44-R-sulfoxide (actin Met(R)O−44 ) to alter F-actin dynamics. These observations contend that the enzyme-driven interconversion of specific Met/Met(R)O residues, similar to the reversible phosphorylation of specific serine, threonine and tyrosine residues 43 , provides a selective means to precisely modulate protein function. Along these lines, our results are supported by recent biochemical experiments demonstrating that one of the mammalian SelRs/MsrBs (MsrB1) reverses MICAL-mediated F-actin disassembly 44 . Moreover, in contrast to a view that oxidation simply plays a destructive role in cell health and protein function, our results indicate that the site-specific and reversible oxidation of proteins is critical for proper cellular physiology. Thus, together, our results uncover a specific reversible redox cellular signalling system that dynamically regulates multiple actin cytoskeletal-mediated events and controls Semaphorin-Plexin repulsion.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
METHODS
Mical-dependent genetic screen. Increasing the levels of Mical in bristle cells
generates actin-rich bristle branches that result from F-actin disassembly and reorganization 5 and are dependent on Semaphorin-1 and PlexinA (refs 5,6) . Thus, a fly line containing a UAS:Mical transgene under the bristle-specific B11-GAL4 driver 5, 20, [47] [48] [49] [50] [51] was constructed and is being used as the basis for a genome-wide dominant enhancer-suppressor genetic screen (that is, we are crossing flies for available deficiencies, transposable element lines, and EMS-generated mutants to this bristle Mical (UAS:Mical, B11-GAL4/ +) transgenic line). This screen therefore generates adult flies expressing one copy of Mical specifically in bristles in a background heterozygous for different mutations. In our previous studies examining genetic interactions with Mical 4,5 , we quantified the number of branches per bristle so as to characterize genes (for example, Semaphorins-Plexins, actin M44L ) that enhanced (increased) or suppressed (decreased) the number of Mical-dependent bristle branches. This Mical-dependent bristle branching using our constructed transgenic line is highly similar/reproducible from animal-toanimal-with the branch being localized at the tip of the bristle process, oriented in the same direction, at the same angle, and of the same length (Fig. 1b , present paper; and Fig. S13a 2 (×1 bristle Mical) from ref. 5). Thus, to make our enhancer-suppressor genetic screening assay even more sensitive, we searched for genes/mutations that either increased the number or length of branches (enhancers) or decreased the number or length of branches (suppressors). The bristles from flies that emerged from our screen were quantified on a 7-point scale. Specifically, all crosses were performed blinded to genotype where the bristles of both male and female adult offspring were scored relative to normal Mical-induced branching. The offspring of the correct genotype were scored (in comparison with normal Mical-induced branching) as either normal Mical-induced branching (score = 0), weak enhanced branching (score = +1), enhanced branching (score = +2), strong enhanced branching (score = +3), weak suppressed branching (score = −1), suppressed branching (score = −2), or strong suppressed branching (score = −3). n = 20 flies per genotype.
Adult bristle characterization. Bristles were examined, imaged and drawn as described previously 5 . The four scutellar bristles were quantified in each animal from young, recently emerged male and female adults 5 , allowing for precise comparison from animal to animal because the bristle morphology of the same four cells could be quantitatively assessed 5 .
Drosophila pupa characterization. Male and female pupae were staged and dissected as described previously 5, 52 . For mCherry-Mical and GFP-SelR localization in bristles, pupae were placed in depression-well slides and imaged. For phalloidin staining, pupae without their cases were placed on double-sided tape and submerged in PBS. The dorsal surface of the thorax was removed, cleaned of fat (muscles were left in place to provide support), fixed with 4% paraformaldehyde (20 min), washed with 0.1% Triton X-100/PBS, and blocked with 5% BSA for 30 min. Thoraxes were incubated in either Far Red phalloidin (1:50; Life Technologies) or a Mical antibody (1:1,500; ref. 13) for 1 h at room temperature, washed, and then either mounted on a glass slide in VectaShield (Vector laboratories), or incubated with a secondary antibody (AlexaFluor 543-conjugated goat anti-rabbit IgG; ABCAM; ab6718; 1:500) before mounting. Pupal bristle actin disruptions were examined/quantified from at least two independent crosses and collections of both GFP-actin-expressing and phalloidin-stained pupae. Bristle pupal imaging employed a Zeiss LSM510 confocal microscope and a ×63 oil objective.
Protein purification. Mical redoxCH protein was as described previously 4, 5 .
Drosophila SelR protein was purified, stored in buffer containing 50 mM Tris-HCl at pH 7.4, 50 mM NaCl, 10 mM MgCl 2 and 1 mM DTT, and used as described previously 23, 25 . The coding sequence of SelR was amplified by PCR from EST LD07760 using the forward primer 5 -AGTCTAACATATGGATAACAAGAGCGA-GAAGG-3 and the reverse primer 5 -AGACAACTCGAGTCACTGCTGGGCAAT-GGGCG-3 , inserted into the pET28a vector containing an amino-terminal 6-His tag (with restriction enzymes NdeI and XhoI), and sequenced. The enzymatic dead SelR C124S was made by mutating the Cys 124 catalytic site to serine 25 . The forward primer 5 -CCCGCAAGCGCTACAGCATCAATTCCGCC-3 and the reverse primer 5 -GGCGGAATTGATGCTGTAGCGCTTGCGGG-3 were used. Mutagenesis was accomplished using the QuickChange strategy (Stratagene) and generated DNA was sequenced to confirm a mutation was present only at the desired site. Purified SelR C124S protein was stored in buffer containing 50 mM Tris-HCl at pH 7.4, 100 mM NaCl, 10 mM MgCl 2 and 1 mM DTT. The Drosophila Eip71CD/MsrA protein was purified, stored in buffer containing 50 mM Tris-HCl at pH 7.4, 100 mM NaCl, 10 mM MgCl 2 and 1 mM DTT, used as described previously 25 , and its activity was confirmed using standard approaches 53 . The coding sequence of Eip71CD/MsrA was amplified by PCR from EST GH10418 using the forward primer 5 -TCACAACATATGTCTCTGACTATTACTTCCAG-3 and the reverse primer 5 -GTCGACAAGCTTGCAGTAGAGACCCTGGCCC-3 , inserted into the pET30 vector containing a C-terminal 6-His tag (with NdeI and HindIII), and sequenced. See also Supplementary Fig. 2 .
Drosophila transgenics and transposable element fly lines. Standard approaches were used to make transgenic flies containing SelR, GFP-SelR, SelR C124S , GFP-SelR C124S , and mCherry-Mical. The SelR coding sequence was amplified from SelR-pET28a with the forward primer 5 -CTGAATTCTACTAGTATGGATAACA-AGAGCGAGAAG-3 and the reverse primer 5 -CTGGTACCTCTAGATCACTGCT-GGGCAATGGGC-3 , inserted into pUAST (with SpeI and XbaI); or for GFP-SelR, sub-cloned into pEGFP-C1, and then GFP-SelR was moved to pUAST (with SpeI and XbaI). DNA containing the C124S point mutation was moved from SelR C124S in pCR2.1 to pUAST-SelR or pUAST-GFP-SelR (with FseI and XbaI). Six separate UAS:SelR and five separate UAS:GFP-SelR transgenic lines were generated and they all suppressed Mical-mediated bristle branching. All nine separate UAS:SelR C124S and six separate UAS:GFP-SelR C124S transgenic lines failed to suppress Mical-mediated bristle branching. All bristle experiments were done with one copy of the UAS:transgene and one copy of the B11-GAL4 driver. For mCherry-Mical, mCherry was PCR amplified with the forward primer 5 -TATGCTAGCTCTAGACCTAGGATGGTGAGCAAGGGCGAGGAT-3 and the reverse primer 5 -TATGCTAGCCTTGTACAGCTCGTCCATGCC-3 . The mCherry complementary DNA was then ligated to the 5 end of the cDNA of Mical in the vector pOT2a using NheI. mCherry-Mical was then moved to pUAST using XbaI. We employed a mCherry-Mical transgenic line that generated (with B11-GAL4) similar bristle branching effects as GFP-tagged and untagged Mical 5 Actin polymerization and sedimentation assays. Actin polymerization assays were performed as described previously using standard approaches 4, 5, 54 . Briefly, purified rabbit skeletal muscle actin (pyrene-labelled; supplied at 0.4-0.6 pyrene dyes per actin monomer; Cytoskeleton) was used to monitor actin polymerization. G-actin was resuspended to 9.2 µM in a G-actin buffer (5 mM Tris-HCl at pH 8.0, 0.2 mM CaCl 2 , 0.2 mM ATP and 1 mM DTT) and incubated on ice for 1 h. Before all experiments, the solution of G-actin was centrifuged for 1 h at 100,000g at 4 • C to remove residual actin nucleating centres. After ultracentrifugation, the actin was further diluted to 2.3 µM using G-actin buffer. Multiple independent experiments were performed for each condition such that Drosophila Mical redoxCH (ref. 5), Drosophila SelR, Drosophila SelR C124S , Drosophila MsrA or hydrogen peroxide (EMD Chemicals) was added to the actin, and polymerization was initiated at 25 • C by adding an equal volume of 2× polymerization buffer (10 mM Tris-HCl at pH 7.5, 100 mM KCl, 4 mM MgCl 2 , 2 mM EGTA, 1 mM DTT and 0.4 mM ATP) to generate a final concentration of 1.15 µM actin. Fluorescence intensity was immediately monitored at 407 nm with excitation at 365 nm by a fluorescence spectrophotometer (Spectra max M2, Molecular Devices).
To examine the ability of SelR to induce Mical-oxidized actin to polymerize into filaments, multiple independent experiments were performed. In particular, purified rabbit muscle actin (Cytoskeleton) or Drosophila actin 5C (generated as described previously 4 ) was resuspended in G-actin buffer to 2.3 µM (as with other assays). The resuspended actin was then polymerized with 2× polymerization buffer in the presence of 600 nM Mical redoxCH and 100 µM NADPH and actin was treated with this Mical/NADPH for 1 h. The Mical-treated actin was then either treated with SelR, SelR C124S or MsrA, in a buffer containing the 10 mM MgCl 2 and 20 mM DTT for 1 h at 37 • C (that is, using conditions that are standardly used with these types of enzyme 53, 55 ). In some cases, the NADPH or/and Mical redoxCH were removed DOI: 10.1038/ncb2871 from Mical-treated actin as described previously 4 (using a centrifugal filter (Amicon Ultra, Ultracel-10K, Millipore) for removal of NADPH and a Mono Q 5/50 GL ion exchange column (GE Healthcare) for removal of Mical) before treating with SelR.
To examine the effects of thioredoxin (Trx), thioredoxin reductase (TrxR), SelR and DTT on restoring Mical-oxidized actin to polymerize into filaments, Mical-oxidized actin was generated and purified as described previously 4 . The activity of TrxR was confirmed as previously described 56 . Purified Mical-oxidized actins at 2.3 µM were treated with 5 µM of Trx (T0910, Sigma), 85 nM of TrxR (T7915, Sigma) or 1.2 µM of SelR in a buffer containing 5 mM MgCl 2 and 10 mM DTT for 1 h at 37 • C and were induced to polymerize with 10× polymerization buffer at room temperature for 1 h. The mixtures were ultracentrifuged at 150,000g for 20 min at 25 • C. Supernatant and pellet fractions were adjusted to the same volumes, subjected to SDS-PAGE and stained with Coomassie blue.
Generation, purification and utilization of SelR-treated Mical-oxidized actin. Rabbit muscle actin at concentrations of 1.1 µM was treated with 600 nM of Mical redoxCH and 100 µM NADPH for 90 min at room temperature in 1× polymerization buffer to generate Mical-oxidized actin (Mical-actin-O). Micalactin-O was then either treated with 2.4 µM of SelR or SelR C124S in buffer containing 10 mM MgCl 2 and 10 mM DTT for 1 h at 37 • C. Samples were then exchanged several times with G-actin buffer using a centrifugal filter (MWCO 10K, Millipore), concentrated, and loaded into a Mono Q 5/50 GL ion exchange column (GE Healthcare) equilibrated with buffer A1 (20 mM Tris-HCl at pH 7.0, 0.2 mM CaCl 2 , 0.1 mM ATP and 0.1 mM DTT). The actin was then eluted with a linear gradient of 0-0.5 M NaCl in buffer A1. The purest fraction was then collected, exchanged to G-actin buffer and concentrated. The actin concentration was determined by a Bradford assay. Each actin sample was then directly subjected to mass spectrometry for analysis or frozen with liquid nitrogen and stored at −80 • C. To examine the ability of SelR-treated Mical-actin-O to re-polymerize (that is, with no SelR or Mical protein present), the purified SelR-treated Mical-actin-O was resuspended to 2.3 µM in G-actin buffer, and polymerization was initiated as described above with 2× polymerization buffer (final concentration of actin was 1.15 µM). The ability of actin to re-polymerize was determined as described by either monitoring the fluorescence intensity or through a sedimentation assay.
Mass spectrometry. The molecular weight of intact protein was measured by an ABI QStar XL mass spectrometer with a nano-electrospray ionization source. Both purified SelR-treated Mical-oxidized actin and purified SelR C124S -treated Mical-oxidized actin in G-actin buffer (1 mg ml −1 ) were diluted 10 times with 1% formic acid in acetonitrile/H 2 O (50:50, v/v), and then infused into the mass spectrometer without desalting. The molecular weight of this purified SelR-treated Mical-oxidized actin is consistent with previous reports of unmodified actin 4, 57 .
Drosophila embryonic axon guidance assays and guidance defects. Embryos (including the SelR trap line CPTI001015) were collected, processed, staged, dissected and analysed as previously described 5, 13, 37 . All embryos (including SelR −/− mutants) were assessed using standard approaches 5, 13, 37 and did not exhibit any gross abnormalities or defects in the attachment of muscles. All assessment of axon guidance defects was also done using standard approaches 5, 13, 37 , an antibody to Fasciclin II (1:4, 1D4 supernatant 58 , Developmental Studies Hybridoma Bank), a Zeiss Axioimager microscope equipped with differential interference contrast optics, a Zeiss Axiocam HR camera, and Zeiss Axiovision software, which allows for imaging and reconstruction of multiple different planes of the embryo 5, 13, 37 . The detailed criteria used to characterize the axon guidance defects are as previously reported 5, 13, 37, 45 . Plexin repulsive CNS guidance defects were as described previously 36, 37, 46 , where embryos were examined for defects in CNS axonal pathfinding including discontinuous or missing first or second CNS longitudinal connectives and/or axons crossing the midline. For all axon guidance assays, at least 2 independent experiments (separate crosses) were performed per genotype with similar results. SelR (EST clone LD07760) in situ hybridization was done using previously described protocols 13, 37 with sense and anti-sense probes.
Drosophila larval neuromuscular innervation, muscles and adult lethality.
Male and female wandering third instar larvae were dissected as described previously 59 . Briefly, larvae were pinned using insect pins in a Sylgard dish (Dow Corning) containing PBS and cut longitudinally between the tracheal tubes on the ventral surface using a razor blade tip and blade holder (Fine Science Tools).
Inner organs and fat were removed except for the brain, and the larvae were filleted using dissecting pins. For the SelR trap line CPTI001015, the larval CNS was immediately viewed and imaged on a Zeiss Discovery M 2 Bio stereomicroscope. For histochemistry, larvae were fixed in methanol and incubated with either rhodamine-conjugated (1:500) or Alexa-Fluor 635-conjugated (1:100) phalloidin (Life Technologies) or a GFP antibody (AlexFluor 488-conjugated rabbit anti-GFP; Life Technologies; A21311; 1:1,000) in PBS for 1-2 h at room temperature. Larvae were then washed in PBS and mounted on glass slides. Larval muscle and synaptic images were taken on a Zeiss LSM510 confocal microscope using a ×40 oil objective. Slices of muscle were taken at a thickness of 0.67 µm. Neuronal muscle innervation was visualized with the aid of CD8-GFP-Shaker (ref. 10). Synaptic length measurements were made in ImageJ by drawing a straight longitudinal line along muscle 6/7 that started at one end of the synapse and ended at the other (as described in ref. 60) . At least two independent experiments (separate crosses) were performed per genotype with similar results. One copy of the ELAV-GAL4 driver was employed for neuronal expression. One copy of the Mef2-GAL4 or the 24B-GAL4 driver was employed for muscle analysis as described previously 10 . Both Mical redoxCH (one copy) or full-length Mical (one or two copies) 5 were employed with similar results. All lethality studies were done with either one copy of the Actin5C-GAL4 (Bloomington Drosophila Stock Center #3954) or the 24B-GAL4 (muscle expression) fly lines, and one copy of Mical redoxCH (ref. 5). Lethality and rescue of lethality was also seen when two copies of full-length Mical 5 and one copy of SelR were used, respectively, with the same GAL4 drivers. The loss of F-actin in muscles was quantified by analysing muscles for a decrease in phalloidin staining, and the areas with decreased F-actin staining were measured and presented as a percentage of the total muscle area. It should be noted that superficial layers of muscles showed phalloidin staining in all genotypes, whereas internal areas of the muscles showed differences between genotypes. Thus, the staining of the superficial layers with phalloidin could be used as a control for the success of the muscle staining. Statistical analysis was performed in GraphPad Prism.
Generation of SelR Delta mutants and characterization of other SelR mutant fly lines. Transposable elements containing FRT sites were employed to generate a small FLP-recombinase-induced deletion of SelR (using the procedure in ref. 61 ; see Supplementary Fig. 6a ). Eight separate white-eyed deletion lines were identified, one of which was verified by sequencing, and on the basis of complementation analysis they all showed similar semi-lethality and bristle defects. We attempted to make homozygous stocks from SelR −/− mutant escaper adults but with multiple attempts we did not get offspring/embryos. Two of these lines, (SelR Delta2 and SelR Delta3 ), were chosen for further study and showed similar results. The SelR RNAi line KK108939 and Eip71CD/MsrA RNAi line KK109010 (Vienna Drosophila RNAi Center) were also employed, as were other transposable element insertions within the SelR locus.
Morphology and F-actin organization of mammalian 3T3 cells. Cell culture assays with 3T3 cells (a gift from M. Rosen, UT Southwestern, USA) were as described previously 4 . Drosophila SelR was inserted into a mammalian expression vector pmCherry-C1 (Clontech) and tagged N-terminally with mCherry. Drosophila GFP-Mical redoxCH was as described previously 4 . 3T3 cells were subpassaged to 6 × 10 6 cells ml −1 in 35-mm uncoated Mattek dishes. After 24 h, cells were transfected with GFP, GFP-Mical redoxCH , mCherry or mCherry-SelR plasmids using Lipofectamine 2000 (Life Technologies). After 24 h, cells were fixed with 4% paraformaldehyde, washed with PBS and permeabilized with 0.1% Triton X-100. Cells were stained with Alexa-Fluor 635 phalloidin (1:50 dilution; Life Technologies), mounted with VectaShield, and imaged with a Zeiss LSM510 confocal microscope using a ×63 oil objective.
Repeatability of experiments.
For each representative image, gel or graph the experiments were repeated at least two separate independent times. At least two different preparations were also examined for the immunofluorescence/reaction product experiments. In all cases, there were no limitations in repeatability. For in vivo experiments, at least two independent experiments (separate crosses per examined genotype) were performed with similar results. For cell culture assays, two independent experiments with duplicate transfections in each were performed with similar results. At least two independent protein purifications and multiple independent actin biochemical experiments were performed with similar results. No statistical method was used to predetermine the sample size. The sample size was chosen on the basis of what is standardly done in the field in published manuscripts. For the animal studies, differences between experimental and control conditions were large, with little variability-and so the sample size was larger than what was needed to ensure adequate power to detect an effect. All animal studies were based on pre-established criteria to compare against age-matched animals. The animal experiments were not randomized. Animals of the correct genotype were determined and all animals that were collected of that genotype were included as data. All genetic screening was done blinded during the experiment and when assessing the outcome. For other genetic experiments, in which the genotype needed to be determined on the basis of different Drosophila genetic/chromosome markers, blinding was not employed. The figure legends list the sample size for each experiment. Statistical tests have been employed on the basis of discussions with professional statisticians on faculty at UT Southwestern. To the best of our knowledge the statistical tests are justified as appropriate.
